CG

Cristina Ghenoiu

Senior Principal at Mubadala Capital

San Francisco, California

Overview

Work Experience

MC
Mubadala Capital

  • Senior Principal

    2023

RC
RA Capital Management, L.P.

  • Principal

    2021 - 2023

CB
Capacity Bio

  • Board Director

    2022 - 2023

SM
Superluminal Medicines, Inc.

  • Board Director

    2022 - 2023

RP
Rivus Pharmaceuticals

  • Board Observer & Scientific Co-Founder

    2022 - 2023

GIVAX

  • Board Director

    2021 - 2023

Lusaris

  • Board Director

    2021 - 2022

E
Epirium

  • SVP of R&D Ops. & New Product Planning

    2020 - 2021

    https://epirium.com/

RP
Rivus Pharmaceuticals

  • Board Observer & Scientific Co-Founder

    2019 - 2021

8
89bio

  • Board Observer

    2018 - 2019

Education

Investments

Capacity Bio

Series A

Total Funding: $35M

Relevant Websites